Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Non-Current Assets (2016 - 2026)

Cytosorbents filings provide 16 years of Non-Current Assets readings, the most recent being $23.5 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 8.62% to $23.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $98.4 million, a 14.86% decrease, with the full-year FY2025 number at $23.5 million, down 8.62% from a year prior.
  • Non-Current Assets hit $23.5 million in Q4 2025 for Cytosorbents, down from $24.4 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $31.5 million in Q2 2024 to a low of $7.8 million in Q1 2021.
  • Median Non-Current Assets over the past 5 years was $27.2 million (2022), compared with a mean of $26.0 million.
  • Biggest five-year swings in Non-Current Assets: soared 249.53% in 2022 and later dropped 21.69% in 2025.
  • Cytosorbents' Non-Current Assets stood at $25.2 million in 2021, then rose by 16.86% to $29.5 million in 2022, then decreased by 6.49% to $27.6 million in 2023, then decreased by 6.49% to $25.8 million in 2024, then decreased by 8.62% to $23.5 million in 2025.
  • The last three reported values for Non-Current Assets were $23.5 million (Q4 2025), $24.4 million (Q3 2025), and $25.0 million (Q2 2025) per Business Quant data.